Age Ageing:急性冠状动脉综合征的老年患者随机采用介入或保守治疗策略后的HRQOL差异比较。

2017-10-10 fengxiangxin MedSci原创

在 After Eighty study这项研究中,患者年龄均在80岁或以上,非ST段抬高型心肌梗死(NSTEMI)的患者和不稳定型心绞痛(UAP)的患者,被随机分到侵入性管理办法组或保守管理办法组。

在 After Eighty study这项研究中,患者年龄均在80岁或以上,非ST段抬高型心肌梗死(NSTEMI)的患者和不稳定型心绞痛(UAP)的患者,被随机分到侵入性管理办法组或保守管理办法组。

研究者试图比较两种不同的管理策略在1年后对健康相关生活质量(HRQOL)的影响。

After Eighty study 是一项前瞻性随机对照多中心临床试验。在这项研究中,共有457例年龄在80岁或以上,有NSTEMI或UAP的患者被随机分为介入治疗组(n = 229,平均年龄:84.7岁。涉及早期冠状动脉造影、对经皮冠状动脉介入治疗的即时评价、冠状动脉旁路移植术,最佳的药物治疗)或保守治疗策略组(N = 228,平均年龄:84.9岁)。SF-36(健康调查简表)被用来评估基线和一年随访的健康相关生活质量(HRQOL)。

基线时,在侵袭和保守组中,分别有208例和216例患者完成了SF-36。在随访时,在侵袭组和保守组中,分别有137例和136例患者完成了SF-36。当比较从随访到基线的变化时,除了微小但是有统计学意义的躯体疼痛差异外,研究者发现两种策略在生活质量评分的任何领域中都没有差异。并且驱体痛差异只出现在SF-36的一个分量表中,所以并不一定具有临床意义。

从基线到1年随访,通过SF-36发现介入治疗策略和保守治疗策略只存在细微的HRQOL差异。

原始出处:


本文系梅斯医学(MEDSCI)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1706832, encodeId=e30d1e0683274, content=<a href='/topic/show?id=15bd30902cc' target=_blank style='color:#2F92EE;'>#冠状动脉综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30902, encryptionId=15bd30902cc, topicName=冠状动脉综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=345831322662, createdName=124985dbm16(暂无昵称), createdTime=Tue Dec 05 21:21:00 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699493, encodeId=c21816994938d, content=<a href='/topic/show?id=8ce7149e209' target=_blank style='color:#2F92EE;'>#QOL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14972, encryptionId=8ce7149e209, topicName=QOL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05b029929630, createdName=lancelotzzl, createdTime=Sat May 26 18:21:00 CST 2018, time=2018-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430980, encodeId=a3d31430980f6, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Oct 12 06:21:00 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508906, encodeId=16b1150890658, content=<a href='/topic/show?id=8e1e2e181f4' target=_blank style='color:#2F92EE;'>#保守治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27181, encryptionId=8e1e2e181f4, topicName=保守治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9d710016703, createdName=cmsvly, createdTime=Thu Oct 12 06:21:00 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1539258, encodeId=7aaf15392586d, content=<a href='/topic/show?id=294e911680' target=_blank style='color:#2F92EE;'>#HRQOL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9116, encryptionId=294e911680, topicName=HRQOL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f2613125915, createdName=pyaili, createdTime=Thu Oct 12 06:21:00 CST 2017, time=2017-10-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1706832, encodeId=e30d1e0683274, content=<a href='/topic/show?id=15bd30902cc' target=_blank style='color:#2F92EE;'>#冠状动脉综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30902, encryptionId=15bd30902cc, topicName=冠状动脉综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=345831322662, createdName=124985dbm16(暂无昵称), createdTime=Tue Dec 05 21:21:00 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699493, encodeId=c21816994938d, content=<a href='/topic/show?id=8ce7149e209' target=_blank style='color:#2F92EE;'>#QOL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14972, encryptionId=8ce7149e209, topicName=QOL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05b029929630, createdName=lancelotzzl, createdTime=Sat May 26 18:21:00 CST 2018, time=2018-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430980, encodeId=a3d31430980f6, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Oct 12 06:21:00 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508906, encodeId=16b1150890658, content=<a href='/topic/show?id=8e1e2e181f4' target=_blank style='color:#2F92EE;'>#保守治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27181, encryptionId=8e1e2e181f4, topicName=保守治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9d710016703, createdName=cmsvly, createdTime=Thu Oct 12 06:21:00 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1539258, encodeId=7aaf15392586d, content=<a href='/topic/show?id=294e911680' target=_blank style='color:#2F92EE;'>#HRQOL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9116, encryptionId=294e911680, topicName=HRQOL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f2613125915, createdName=pyaili, createdTime=Thu Oct 12 06:21:00 CST 2017, time=2017-10-12, status=1, ipAttribution=)]
    2018-05-26 lancelotzzl
  3. [GetPortalCommentsPageByObjectIdResponse(id=1706832, encodeId=e30d1e0683274, content=<a href='/topic/show?id=15bd30902cc' target=_blank style='color:#2F92EE;'>#冠状动脉综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30902, encryptionId=15bd30902cc, topicName=冠状动脉综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=345831322662, createdName=124985dbm16(暂无昵称), createdTime=Tue Dec 05 21:21:00 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699493, encodeId=c21816994938d, content=<a href='/topic/show?id=8ce7149e209' target=_blank style='color:#2F92EE;'>#QOL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14972, encryptionId=8ce7149e209, topicName=QOL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05b029929630, createdName=lancelotzzl, createdTime=Sat May 26 18:21:00 CST 2018, time=2018-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430980, encodeId=a3d31430980f6, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Oct 12 06:21:00 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508906, encodeId=16b1150890658, content=<a href='/topic/show?id=8e1e2e181f4' target=_blank style='color:#2F92EE;'>#保守治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27181, encryptionId=8e1e2e181f4, topicName=保守治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9d710016703, createdName=cmsvly, createdTime=Thu Oct 12 06:21:00 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1539258, encodeId=7aaf15392586d, content=<a href='/topic/show?id=294e911680' target=_blank style='color:#2F92EE;'>#HRQOL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9116, encryptionId=294e911680, topicName=HRQOL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f2613125915, createdName=pyaili, createdTime=Thu Oct 12 06:21:00 CST 2017, time=2017-10-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1706832, encodeId=e30d1e0683274, content=<a href='/topic/show?id=15bd30902cc' target=_blank style='color:#2F92EE;'>#冠状动脉综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30902, encryptionId=15bd30902cc, topicName=冠状动脉综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=345831322662, createdName=124985dbm16(暂无昵称), createdTime=Tue Dec 05 21:21:00 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699493, encodeId=c21816994938d, content=<a href='/topic/show?id=8ce7149e209' target=_blank style='color:#2F92EE;'>#QOL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14972, encryptionId=8ce7149e209, topicName=QOL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05b029929630, createdName=lancelotzzl, createdTime=Sat May 26 18:21:00 CST 2018, time=2018-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430980, encodeId=a3d31430980f6, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Oct 12 06:21:00 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508906, encodeId=16b1150890658, content=<a href='/topic/show?id=8e1e2e181f4' target=_blank style='color:#2F92EE;'>#保守治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27181, encryptionId=8e1e2e181f4, topicName=保守治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9d710016703, createdName=cmsvly, createdTime=Thu Oct 12 06:21:00 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1539258, encodeId=7aaf15392586d, content=<a href='/topic/show?id=294e911680' target=_blank style='color:#2F92EE;'>#HRQOL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9116, encryptionId=294e911680, topicName=HRQOL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f2613125915, createdName=pyaili, createdTime=Thu Oct 12 06:21:00 CST 2017, time=2017-10-12, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1706832, encodeId=e30d1e0683274, content=<a href='/topic/show?id=15bd30902cc' target=_blank style='color:#2F92EE;'>#冠状动脉综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30902, encryptionId=15bd30902cc, topicName=冠状动脉综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=345831322662, createdName=124985dbm16(暂无昵称), createdTime=Tue Dec 05 21:21:00 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699493, encodeId=c21816994938d, content=<a href='/topic/show?id=8ce7149e209' target=_blank style='color:#2F92EE;'>#QOL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14972, encryptionId=8ce7149e209, topicName=QOL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05b029929630, createdName=lancelotzzl, createdTime=Sat May 26 18:21:00 CST 2018, time=2018-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430980, encodeId=a3d31430980f6, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Oct 12 06:21:00 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508906, encodeId=16b1150890658, content=<a href='/topic/show?id=8e1e2e181f4' target=_blank style='color:#2F92EE;'>#保守治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27181, encryptionId=8e1e2e181f4, topicName=保守治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9d710016703, createdName=cmsvly, createdTime=Thu Oct 12 06:21:00 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1539258, encodeId=7aaf15392586d, content=<a href='/topic/show?id=294e911680' target=_blank style='color:#2F92EE;'>#HRQOL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9116, encryptionId=294e911680, topicName=HRQOL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f2613125915, createdName=pyaili, createdTime=Thu Oct 12 06:21:00 CST 2017, time=2017-10-12, status=1, ipAttribution=)]
    2017-10-12 pyaili